HR 5354 RFS
‘‘(C) providing postpartum care for women 
with gestational diabetes; 
‘‘(D) tracking cases where women with a 
history of gestational diabetes developed type 2 
diabetes; 
‘‘(E) educating mothers with a history of 
gestational diabetes about the increased risk of 
their child developing diabetes; 
‘‘(F) working to prevent gestational diabe-
tes and prevent or delay the development of 
type 2 diabetes in women with a history of ges-
tational diabetes; and 
‘‘(G) achieving outcomes designed to assess 
the efficacy and cost-effectiveness of interven-
tions that can inform decisions on long-term 
sustainability, including third-party reimburse-
ment. 
‘‘(3) APPLICATION.—An eligible entity desiring 
to receive a grant under this subsection shall submit 
to the Secretary— 
‘‘(A) an application at such time, in such 
manner, and containing such information as the 
Secretary may require; and 
‘‘(B) a plan to— 
VerDate Mar 15 2010 
02:08 Nov 16, 2010
Jkt 099200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H5354.RFS
H5354
jbell on DSKDVH8Z91PROD with BILLS
HR 5354 RFS
‘‘(i) lower the rate of gestational dia-
betes during pregnancy; or 
‘‘(ii) develop methods of tracking 
women with a history of gestational diabe-
tes and develop effective interventions to 
lower the incidence of the recurrence of 
gestational diabetes in subsequent preg-
nancies and the development of type 2 dia-
betes. 
‘‘(4) USES OF FUNDS.—An eligible entity re-
ceiving a grant under this subsection shall use the 
grant funds to carry out demonstration projects de-
scribed in paragraph (1), including— 
‘‘(A) expanding community-based health 
promotion education, activities, and incentives 
focused on the prevention of gestational diabe-
tes and development of type 2 diabetes in 
women with a history of gestational diabetes; 
‘‘(B) aiding State- and tribal-based diabe-
tes prevention and control programs to collect, 
analyze, disseminate, and report surveillance 
data on women with, and at risk for, gesta-
tional diabetes, the recurrence of gestational di-
abetes in subsequent pregnancies, and, for 
VerDate Mar 15 2010 
02:08 Nov 16, 2010
Jkt 099200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H5354.RFS
H5354
jbell on DSKDVH8Z91PROD with BILLS
HR 5354 RFS
women with a history of gestational diabetes, 
the development of type 2 diabetes; and 
‘‘(C) training and encouraging health care 
providers— 
‘‘(i) to promote risk assessment, high- 
quality care, and self-management for ges-
tational diabetes and the recurrence of ges-
tational diabetes in subsequent preg-
nancies; and 
‘‘(ii) to prevent the development of 
type 2 diabetes in women with a history of 
gestational diabetes, and its complications 
in the practice settings of the health care 
providers. 
‘‘(5) REPORT.—Not later than 4 years after the 
date of the enactment of this section, the Secretary 
shall prepare and submit to the Congress a report 
concerning the results of the demonstration projects 
conducted through the grants awarded under this 
subsection. 
‘‘(6) DEFINITION
OF
ELIGIBLE
ENTITY.—In 
this subsection, the term ‘eligible entity’ means a 
nonprofit organization (such as a nonprofit academic 
center or community health center) or a State, trib-
al, or local health agency. 
VerDate Mar 15 2010 
02:08 Nov 16, 2010
Jkt 099200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H5354.RFS
H5354
jbell on DSKDVH8Z91PROD with BILLS
HR 5354 RFS
‘‘(7) AUTHORIZATION
OF
APPROPRIATIONS.— 
There is authorized to be appropriated to carry out 
this subsection $5,000,000 for each fiscal year 2012 
through 2016. 
‘‘(d) POSTPARTUM FOLLOW-UP REGARDING GESTA-
TIONAL DIABETES.—The Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion, shall work with the State- and tribal-based diabetes 
prevention and control programs assisted by the Centers 
to encourage postpartum follow-up after gestational diabe-
tes, as medically appropriate, for the purpose of reducing 
the incidence of gestational diabetes, the recurrence of 
gestational diabetes in subsequent pregnancies, the devel-
opment of type 2 diabetes in women with a history of ges-
tational diabetes, and related complications.’’. 
Passed the House of Representatives September 30 
(legislative day September 29), 2010. 
Attest: 
LORRAINE C. MILLER, 
Clerk. 
VerDate Mar 15 2010 
02:08 Nov 16, 2010
Jkt 099200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H5354.RFS
H5354
jbell on DSKDVH8Z91PROD with BILLS